Sunmax Biotechnology Co (ROCO:4728) Other Stockholders Equity: NT$275 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4728 Sunmax Biotechnology Co Ltd ROCO:4728
88 GF Score
Price NT$383.00
GF Value NT$342.94
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Sunmax Biotechnology Co Other Stockholders Equity?

Sunmax Biotechnology Co ROCO:4728 +2.00% 88 Other Stockholders Equity is NT$275 Mil as of Mar. 2026. GuruFocus rates ROCO:4728 with a GF Score™ of 88/100 and a GF Value™ of NT$342.94 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Sunmax Biotechnology Co's Other Stockholders Equity for the quarter that ended in Mar. 2026 was NT$275 Mil.

Sunmax Biotechnology Co's quarterly Other Stockholders Equity increased from Sep. 2025 (NT$253 Mil) to Dec. 2025 (NT$269 Mil) and increased from Dec. 2025 (NT$269 Mil) to Mar. 2026 (NT$275 Mil).

Sunmax Biotechnology Co's annual Other Stockholders Equity increased from Dec. 2023 (NT$113 Mil) to Dec. 2024 (NT$196 Mil) and increased from Dec. 2024 (NT$196 Mil) to Dec. 2025 (NT$269 Mil).

Sunmax Biotechnology Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Sunmax Biotechnology Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunmax Biotechnology Co Other Stockholders Equity Chart

Sunmax Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.66 78.53 113.38 196.44 268.85

Sunmax Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 200.94 243.04 253.35 268.85 274.74
ROCO:4728
88GF Score
Sunmax Biotechnology Co Ltd ROCO:4728
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunmax Biotechnology Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of NT$275 Mil mean?
Sunmax Biotechnology Co (ROCO:4728) has a Other Stockholders Equity of NT$275 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sunmax Biotechnology Co and its competitors.
Is Sunmax Biotechnology Co's Other Stockholders Equity too high?
Sunmax Biotechnology Co's current Other Stockholders Equity is NT$275 Mil. Overall, Sunmax Biotechnology Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sunmax Biotechnology Co's Other Stockholders Equity compare to VRTX and REGN?
Sunmax Biotechnology Co's Other Stockholders Equity of NT$275 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sunmax Biotechnology Co and its competitors. Sunmax Biotechnology Co's current Other Stockholders Equity is NT$275 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunmax Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sunmax Biotechnology Co (ROCO:4728) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$342.94, compared to a current price of NT$383.00 — trading 11.7% above its estimated fair value. The current Other Stockholders Equity is NT$275 Mil. Sunmax Biotechnology Co's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Sunmax Biotechnology Co (ROCO:4728), the current Other Stockholders Equity is NT$275 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunmax Biotechnology Co (ROCO:4728) Overvalued in 2026?

Based on GuruFocus' analysis, Sunmax Biotechnology Co stock appears to be overvalued. The current stock price of NT$383.00 is trading 11.7% above its estimated GF Value™ of NT$342.94. GuruFocus considers Sunmax Biotechnology Co to be Modestly Overvalued.

Key valuation signals for ROCO:4728:

  • Other Stockholders Equity: NT$275 Mil
  • GF Value™: NT$342.94 vs. price of NT$383.00 (11.7% above fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4728 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunmax Biotechnology Co Business Description

Address Huandong Road, New Urban District, 1st Floor, No. 10, Lane 31, Section 1, Tainan Science Industrial Park, Tainan, TWN
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
88GF Score

Get the complete analysis for ROCO:4728

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$383.00
Price
NT$342.94
GF Value